市場調查報告書
商品編碼
1182092
家禽保健全球市場規模研究和預測,按產品類型、試驗類型和地區分析,2022-2029Global Poultry Healthcare Market Size study & Forecast, by Product Type, Test Type and Regional Analysis, 2022-2029 |
家禽保健是指家畜和其他家禽的治療。
將各種動物衍生產品推向市場。 由於人畜共患疾病發病率上升以及對家禽衍生食品和雜貨的需求增加等因素,家禽保健市場正在擴大。 此外,由於私營公司的戰略舉措和醫療保健行業的增長,預計市場將擴大。 該市場由 Elanco、Zoetic Inc、Merck &Co Inc、Hester Biosciences Limited 等公司主導。
疾病的治療需求隨著病例數量的增加而顯著增加,預計這將在預測期內推動市場增長。 例如,根據加拿大政府公佈的2022年數據,截至2022年6月,艾伯塔省預計將有963,889隻鳥類感染禽流感,其次是安大略省560,536只,魁北克省300,835只。 此外,根據 2021 年 11 月發表的論文“印度哈裡亞納邦工業家禽和庭院家禽中新城疫病毒的流行情況”,從 2018 年 3 月到 2020 年 3 月進行了分層調查。 使用 M 基因 rRT-PCR 顯示,商品肉雞和蛋雞的新城疫病毒 (NDV) 檢測均呈陽性。 根據同一來源,患有輕度呼吸道疾病的雞群新城疫病毒的流行率較高(15.7%),其次是健康雞群(9.1%)和病雞群(3.0%)。 然而,假藥的使用、市場上缺乏獸醫和熟練的農場工人短缺會阻礙市場增長。
全球家禽保健市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 北美在收入方面佔據主導地位,對雞肉衍生食品的需求不斷增長。 根據 Nass.usda.gov 的數據,2020 年肉雞總產量為 217 億美元,比 2019 年下降 23%。 2020年肉雞爆發總量為92.2億隻,較2019年有所增加。 2020年肉雞鮮重594億斤,比2019年增長2%。 由於上升,預計亞太地區在預測期內將顯著增長。
這項研究的目的是定義近年來各個細分市場和國家/地區的市場規模,並預測它們在未來幾年的價值。 該報告旨在包括被調查國家工業的定性和定量方面。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Poultry Healthcare Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Poultry Healthcare refers to the method of treating the animals and other poultry animals. For deriving various animal-based products in the market. The Poultry Healthcare market is expanding because of factors such as rising Occurrence of Zoonotic Diseases and rising demand for Poultry-derived Food and food Products. The market is expected to rise owing to strategic initiatives by the private players in the market and rising healthcare industry. The market is dominated by Elanco, Zoetic Inc, Merck & Co Inc, Hester Biosciences Limited and others.
The need to treat the disorders has increased significantly as well as the number of cases, which is anticipated to fuel market growth during the forecast period. For instance, the 2022 figures released by the Government of Canada show that as of June 2022, it was anticipated that 963,889 birds in Alberta will be affected by avian influenza in 2022, followed by 560,536 birds in Ontario and 300,835 birds in Quebec. Further, according to a November 2021 paper titled "Prevalence of Newcastle Disease Virus in Industrial and Backyard Poultry in Haryana, India," a stratified research study was carried out from March 2018 to March 2020. Using the M gene rRT-PCR, it was revealed that both commercial broilers and layers tested positively for Newcastle disease virus (NDV). According to the same source, flocks with mild respiratory problems showed a higher prevalence of Newcastle disease virus (15.7%), followed by healthy (9.1%) and sick (3.0%) flocks. However, use of counterfeit medicines, lack of veterinarians in the market and shortage of skilled farm workers may halt market growth.
The key regions considered for the Global Poultry Healthcare Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, rising demand for poultry-derived food products. According to Nass.usda.gov, Broilers produced in 2020 were valued at USD 21.7 billion, a 23% decrease from 2019. In 2020, 9.22 billion broilers were generated in total, an increase from 2019. In 2020, 59.4 billion pounds of live weight broilers were generated, an increase of 2% from 2019. Asia Pacific is expected to grow significantly during the forecast period, owing to rising
Major market players included in this report are:
Indovax
Thermo Fisher Scientific Inc.
Boehringer Ingelheim GmbH
Ceva Sante Animale
Merck & Co Inc
IDEXX Laboratories, Inc.
Megacor Diagnostik GmbH
Elanco
Zoetis Inc.
Hester Biosciences Limited
Recent Developments in the Market:
Global Poultry Healthcare Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product Type, Test Type and Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product type:
Vaccines
Parasiticides
Anti-Infectives
Medical Feed Additives
Others
By Test Type:
Elisa Test
PCR Test
Molecular Diagnostic Test
Other Test Types
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable